Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
Saudi Arabia · Delayed Price · Currency is SAR 36.54
-0.02 (-0.05%)
Jun 11, 2026, 3:12 PM AST
TADAWUL:4017 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, TADAWUL:4017 stock has a consensus rating of "Hold" and an average price target of SAR 42.02. The average 1-year stock price forecast is 15.00% higher than the current stock price, while the lowest is SAR 38.00 (+4.00%) and the highest is SAR 45.00 (+23.15%).
Price Target: SAR 42.02 (+15.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for TADAWUL:4017 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
3.64B
from 3.09B
Increased by 17.74%
Revenue Next Year
4.30B
from 3.64B
Increased by 18.31%
EPS This Year
1.39
from 1.26
Increased by 10.30%
EPS Next Year
1.76
from 1.39
Increased by 26.98%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.6B | ||
| Avg | 3.6B | ||
| Low | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.7% | ||
| Avg | 17.7% | ||
| Low | 17.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.39 | ||
| Avg | 1.39 | ||
| Low | 1.39 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.3% | ||
| Avg | 10.3% | ||
| Low | 10.3% |